The cost of COPD exacerbations: A university hospital - Based study in Greece

Respiratory Medicine

Volumn 105, Issue 3, 2011, Pages 402-409

  Geitona, Mary ^a,d   Hatzikou, Magdalini ^a   Steiropoulos, Paschalis ^b   Alexopoulos, Evangelos C ^c   Bouros, Demosthenes ^b  

^a UNIVERSITY OF PELOPONNESE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

^d Magnisias Street 96 ^*  (Greece)

Author keywords

COPD; Cost; Exacerbations; Greece; Hospitalization; Rural

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG COST; FEMALE; FUNDING; GREECE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY; SOCIAL INSURANCE; UNIVERSITY HOSPITAL;

AGED; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FEMALE; GREECE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SMOKING;

EID: 79151485420     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.09.020     Document Type: Article

References (40)

1. D.M. Halpin, and M. Miravitlles Chronic obstructive pulmonary disease: the disease and its burden to society Proc Am Thorac Soc 3 2006 619 623 (Pubitemid 44411630)
2. J.B. Soriano, W.C. Maier, and P. Egger Recent trends in physician diagnosed COPD in women and men in the UK Thorax 55 2000 789 794
3. S.J. Kim, M.H. Suk, and H.M. Choi The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea Int J Tuberc Lung Dis 10 2006 1393 1398
4. R.J. Halbert, J.L. Natoli, and A. Gano Global burden of COPD: systematic review and meta-analysis Eur Respir J 28 2006 523 532
5. K.R. Chapman, D.M. Mannino, and J.B. Soriano Epidemiology and costs of chronic obstructive pulmonary disease Eur Respir J 27 2006 188 207
6. N. Tzanakis, U. Anagnostopoulou, and V. Filaditaki Prevalence of COPD in Greece Chest 125 2004 892 900
7. World Health Organization Global burden of disease 2004 update 2008 World Health Organization Press Geneva Available at: http://www.who.int/respiratory/ copd/burden/en/index.html [accessed 31.5.2010]
8. J.M. Anto, P. Vermeire, and J. Vestbo Epidemiology of chronic obstructive pulmonary disease Eur Respir J 17 2001 982 994
9. G. Viegi, M. Pedreschi, and F. Pistelli Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition Chest 117 Suppl. 2 2000 339S 345S
10. T. Izumi Chronic obstructive pulmonary disease in Japan Curr Opin Pulm Med 8 2002 102 105
11. S. Bakke, V. Baste, and R. Hanoa Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents Thorax 46 1991 863 870
12. E.F.M. Wouters Economic analysis of the confronting COPD survey: an overview of results Respir Med 97 Suppl. 3 2003 S3 S14
13. M.T. Halpern, R.H. Stanford, and R. Borker The burden of COPD in the U.S.A.: results from the confronting COPD survey Respir Med 97 Suppl. 3 2003 S81 S89
14. J. Garcia-Aymerich, J. Escarrabill, and R.M. Marrades Differences in COPD care among doctors who control the disease: general practitioner vs. pneumologist Respir Med 100 2006 332 339
15. E. Kosmas, H. Vey, and M.K. Fraggou Effects of pulmonary rehabilitation on exacerbation rate, hospitalization, length of hospital stay and public health economics in patient with moderate to severe chronic obstructive pulmonary disease Chest 128 4 2005 254
16. L. Fuso, R.A. Incalzi, and R. Pistelli Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease Am J Med 98 1995 272 277
17. S.A. Jansson, F. Andersson, and S. Borg Costs of COPD in Sweden according to disease severity Chest 122 2002 1994 2002
18. M.P. Rutten van-Molken, and T.L. Feenstra The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands Pharmacoeconomics 19 Suppl. 2 2001 1 6
19. S.D. Sullivan, S.D. Ramsey, and T.A. Lee The economic burden of COPD Chest 117 2000 5S 9S
20. L. Jacobson, P. Hertzman, and C.G. Lofdahl The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991 Respir Med 94 2000 247 255
21. M.M. Ward, H.S. Javitz, and W.M. Smith Direct medical cost of chronic obstructive pulmonary disease in the U.S.A Respir Med 94 2000 1123 1129
22. M. Britton The burden of COPD in the U.K.: results from the Confronting COPD survey Respir Med 97 Suppl. 3 2003 S71 S79
23. J.F. Masa, V. Sobradillo, and C. Villasante Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study Arch Bronconeumol 40 2004 72 79
24. K.I. Gourgoulianis, K. Hristou, and P.A. Molyvdas Detection of COPD in high-risk populations Chest 121 2002 1721
25. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of COPD 2009 Medical Communications Resources, Inc Gig Harbour, WA Updated
26. S. Wordsworth, A. Ludbrook, and F. Caskey Collecting unit cost data in multicentre studies creating comparable methods Eur J Health Econ 6 2005 38 44
27. A. Leftakis, and M. Geitona Cost analysis and estimation of thoracic surgical patients with lung cancer in Greece: the case of Sotiria ICU Intensive Crit Care Nurs 17 2001 322 330
28. B. Detournay, C. Pribil, and M. Fournier The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France Value Health 7 2004 168 174
29. J.B. Oostenbrink, and M.P.M.H. Rutten-Van Molken Resource use and risk factors in high-cost exacerbations of COPD Respir Med 98 2004 883 891
30. D. Koleva, N. Motterlini, P. Banfi on behalf of the Study Group BIC Healthcare costs of COPD in Italian referral centres: a prospective study Respir Med 101 2007 2312 2320
31. F. Andersson, S. Borg, and S.A. Jansson The costs of exacerbations in chronic obstructive pulmonary disease (COPD) Respir Med 96 2002 700 708
32. GDP PPP (y2006) http://stats.oecd.org/Index.aspx?datasetcode = SNA-TABLE4
33. OECD Health Indicators Health at a glance 2005 OECD Publishing
34. C. Vardavas, and A. Kafatos Smoking policy and prevalence in Greece: an overview Eur J Public Health 17 2006 211 213
35. L. Sichletides, D. Chloros, and I. Tsiotsios High prevalence of smoking in Northern Greece Prim Care Resp J 15 2006 92 97
36. N. Mittmann, L. Kuramoto, and S.J. Seung The cost of moderate and severe COPD exacerbations to the Canadian healthcare system Respir Med 102 2008 413 421
37. M.T. Halpern, A. Musin, and S. Sondhi Economic analysis of the confronting COPD survey: methodology Respir Med 97 Suppl. C 2003 S15 S22
38. J.A. Schreyogg Micro-costing approach to estimating hospital costs for appendectomy in a cross-European context Health Econ 17 S1 2008 S59 S69
39. A.M. McLaughlin, J. Hardt, and J.B. Canavan Determining the economic cost of ICU treatment: a prospective "micro-costing" study Intensive Care Med 35 2009 2135 2140
40. A. Tzonou, G. Marangoudakis, and D. Trichopoulos Urban living, tobacco smoking and chronic obstructive pulmonary disease: a study in Athens Epidemiology 3 1992 57 60